bar_chartAcorda Therapeutics, Inc.
ACOR | Healthcare | Biotechnology
bar_chartPerformance
bar_chartPerformance(Quarter)
bar_chartCash Flow
bar_chartCash Flow(Quarter)
bar_chartInstitutional Holders
Holder |
% Out |
Shares |
Renaissance Technologies, LLC |
8.0% |
3,837,961 |
Vanguard Group, Inc. (The) |
5.97% |
2,862,433 |
Point72 Asset Management, L.P. |
4.17% |
2,000,000 |
Acadian Asset Management |
3.83% |
1,835,064 |
Parallax Volatility Advisers, LLC |
3.36% |
1,610,567 |
Blackrock Inc. |
2.26% |
1,086,230 |
Jacobs Levy Equity Management, Inc. |
1.85% |
885,299 |
Gsa Capital Partners Llp |
1.4% |
672,158 |
Federated Hermes, Inc. |
1.34% |
643,258 |
Invesco Ltd. |
1.19% |
573,061 |
bar_chartMutual Fund Holders
Holder |
% Out |
Shares |
Vanguard Total Stock Market Index Fund |
2.85% |
1,366,942 |
Vanguard Explorer Fund, Inc. |
1.62% |
775,332 |
Vanguard Extended Market Index Fund |
1.42% |
681,674 |
Federated Hermes MDT Small Cap Core Fund |
1.31% |
627,148 |
Vanguard Horizon Fund-Strategic Small-Cap Equity Fund |
1.27% |
610,867 |
Invesco ETF Tr-Invesco FTSE RAFI US 1500 Small-Mid ETF |
1.18% |
565,957 |
DFA U.S. Small Cap Series |
1.0% |
481,268 |
Vanguard Variable Insurance Fund-Small Company Growth |
0.77% |
367,609 |
DFA U.S. Targeted Value Portfolio |
0.67% |
321,023 |
DFA U.S. Core Equity 2 Portfolio |
0.53% |
255,787 |